trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Leukemia D007938 74 associated lipids
Leishmaniasis D007896 19 associated lipids
Keloid D007627 12 associated lipids
Chromosome Inversion D007446 1 associated lipids
Inflammation D007249 119 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Hypesthesia D006987 1 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypertension D006973 115 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Mukhopadhyay NK et al. Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. 2006 Ann. Thorac. Surg. pmid:16488717
Swanson S Invited commentary. 2006 Ann. Thorac. Surg. pmid:16488718
Song YF et al. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. 2006 J. Clin. Pathol. pmid:16489177
Rokhlin OW et al. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. 2006 Mol. Cancer Res. pmid:16513842
Williams SA et al. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. 2006 EMBO J. pmid:16319923
Kiefer J et al. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells. 2006 Br. J. Nutr. pmid:17092367
Kishigami S et al. Epigenetic abnormalities of the mouse paternal zygotic genome associated with microinsemination of round spermatids. 2006 Dev. Biol. pmid:16325170
Mogal A and Abdulkadir SA Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. 2006 Mol. Cell. Probes pmid:16326072
Trapp J et al. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. 2006 J. Med. Chem. pmid:17149860
Rebbaa A et al. The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. 2006 Cell Death Differ. pmid:16557274
Suuronen T et al. Characterization of the pro-inflammatory signaling induced by protein acetylation in microglia. 2006 Neurochem. Int. pmid:16797784
Krishnan M et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. 2006 FASEB J. pmid:16246867
Wallace DM et al. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16799012
Pampalakis G and Sotiropoulou G Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. 2006 Biol. Chem. pmid:16800739
Wang Y et al. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. 2006 Arthritis Rheum. pmid:16802366
Morinobu A et al. Trichostatin A cooperates with Fas-mediated signal to induce apoptosis in rheumatoid arthritis synovial fibroblasts. 2006 J. Rheumatol. pmid:16755652
Dannenberg LO et al. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. 2006 Alcohol. Clin. Exp. Res. pmid:16737450
Cabrero JR et al. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity. 2006 Mol. Biol. Cell pmid:16738306
Vulcano F et al. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. 2006 Exp. Cell Res. pmid:16739251
Qi H and Ratnam M Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. 2006 Cancer Res. pmid:16740727
Nusinzon I and Horvath CM Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. 2006 Mol. Cell. Biol. pmid:16581785
Ibanez de Caceres I et al. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. 2006 Cancer Res. pmid:16707423
Kim MY et al. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. 2006 Mol. Endocrinol. pmid:16497729
Leng Y and Chuang DM Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. 2006 J. Neurosci. pmid:16837598
Clem BF and Clark BJ Association of the mSin3A-histone deacetylase 1/2 corepressor complex with the mouse steroidogenic acute regulatory protein gene. 2006 Mol. Endocrinol. pmid:16109738
Yao J et al. NF-kappaB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells. 2006 Pharmacol. Res. pmid:17005413
Inoue K et al. Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. 2006 Arterioscler. Thromb. Vasc. Biol. pmid:17008592
Baqir S and Smith LC Inhibitors of histone deacetylases and DNA methyltransferases alter imprinted gene regulation in embryonic stem cells. 2006 Cloning Stem Cells pmid:17009896
Hong ZY et al. [Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray]. 2006 Ai Zheng pmid:16965673
Banwell CM et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. 2006 Clin. Cancer Res. pmid:16609009
Mühlethaler-Mottet A et al. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. 2006 BMC Cancer pmid:16930472
Suzuki T et al. Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate. 2006 J. Med. Chem. pmid:16884291
Kim TY et al. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. 2006 Cancer Res. pmid:16885346
Kimura N et al. Alteration of developmental program in Paramecium by treatment with trichostatin a: a possible involvement of histone modification. 2006 Protist pmid:16839811
Monte M et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16847267
Zaveri NT et al. Regulation of the prepronociceptin gene and its effect on neuronal differentiation. 2006 Gene pmid:16935438
Osborn NK et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. 2006 Clin. Gastroenterol. Hepatol. pmid:16469682
Baraz L et al. Tumor suppressor p53 regulates heparanase gene expression. 2006 Oncogene pmid:16474844
Gialitakis M et al. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. 2006 Nucleic Acids Res. pmid:16452299
Cecconi D et al. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. 2005 Nov-Dec J. Proteome Res. pmid:16335935
Garcia BA et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. 2005 Nov-Dec J. Proteome Res. pmid:16335948
Huang W et al. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. 2005 J. Biol. Chem. pmid:15647279
Choi JH et al. Trichostatin A attenuates airway inflammation in mouse asthma model. 2005 Clin. Exp. Allergy pmid:15649272
Varshochi R et al. ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. 2005 J. Biol. Chem. pmid:15557281
Goeman F et al. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. 2005 Mol. Cell. Biol. pmid:15601862
Tai HH et al. Dynamic histone acetylation of late embryonic genes during seed germination. 2005 Plant Mol. Biol. pmid:16307366
Noh EJ et al. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells. 2005 Cancer Res. pmid:16357148
Wetzel M et al. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. 2005 J. Neurosurg. pmid:16383255
Lee JH et al. Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1. 2005 J. Endocrinol. pmid:16293776
Hazzalin CA and Mahadevan LC Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: analysis at c-fos and c-jun. 2005 PLoS Biol. pmid:16262446
Hohl M and Thiel G Cell type-specific regulation of RE-1 silencing transcription factor (REST) target genes. 2005 Eur. J. Neurosci. pmid:16262660
Bernes S et al. Epigenetic and classical activation of Entamoeba histolytica heat shock protein 100 (EHsp100) expression. 2005 FEBS Lett. pmid:16263115
Gao S et al. CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. 2005 Thromb. Haemost. pmid:16268485
Li XX et al. Function of c-Fos-like and c-Jun-like proteins on trichostatin A-induced G2/M arrest in Physarum polycephalum. 2005 Acta Biochim. Biophys. Sin. (Shanghai) pmid:16270156
Francia G et al. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents. 2005 Mol. Cancer Ther. pmid:16227397
Chou SD et al. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. 2005 Int. Immunol. pmid:16210330
Osada H et al. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. 2005 Mol. Carcinog. pmid:16163707
Rogier E et al. A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection. 2005 Kidney Int. pmid:16164666
Di-Poï N et al. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. 2005 J. Biol. Chem. pmid:16166081
Spengler ML et al. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. 2005 Cell. Signal. pmid:15494207
Valenzuela-Fernández A et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. 2005 Mol. Biol. Cell pmid:16148047
Davis FJ et al. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15388503
Korutla L et al. The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures. 2005 J. Neurochem. pmid:16033423
Shindo N et al. The ESC-E(Z) complex participates in the hedgehog signaling pathway. 2005 Biochem. Biophys. Res. Commun. pmid:15652519
Kemp MG et al. The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells. 2005 Nucleic Acids Res. pmid:15653633
Huang H et al. MEIS C termini harbor transcriptional activation domains that respond to cell signaling. 2005 J. Biol. Chem. pmid:15654074
Danam RP et al. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. 2005 Mol. Cancer Ther. pmid:15657354
Li Y et al. Histone deacetylation is required for progression through mitosis in tobacco cells. 2005 Plant J. pmid:15659094
Zhao Y et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. 2005 J. Exp. Biol. pmid:15695762
Hooven LA et al. Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a]pyrene DNA adduct formation in human cells. 2005 Bioorg. Med. Chem. Lett. pmid:15713371
Chen B et al. Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:15713393
Touma SE et al. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. 2005 Clin. Cancer Res. pmid:15867260
Fish JE et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. 2005 J. Biol. Chem. pmid:15870070
Dyson MH et al. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. 2005 J. Cell. Sci. pmid:15870105
Reid G et al. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. 2005 Oncogene pmid:15870696
Kim MS et al. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). 2005 Exp. Cell Res. pmid:15878336
Rosenqvist N et al. Inhibition of chromatin condensation prevents transgene silencing in a neural progenitor cell line transplanted to the rat brain. 2005 Cell Transplant pmid:15881422
Gonçalves J et al. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. 2005 Clin. Chem. Lab. Med. pmid:15843208
Gunin AG et al. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. 2005 J. Endocrinol. pmid:15930180
Komata T et al. Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. 2005 Int. J. Oncol. pmid:15809727
Wittich S et al. Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. 2005 Anticancer Drugs pmid:15930892
Kaneda R et al. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes. 2005 Circ. Res. pmid:16002748
Kusy S et al. Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. 2005 Biochim. Biophys. Acta pmid:16005989
Rho JH et al. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation. 2005 Int. J. Oncol. pmid:16010429
Choi YH Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. 2005 Int. J. Oncol. pmid:16010430
Taddei A et al. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? 2005 EMBO Rep. pmid:15940285
Gray SG et al. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. 2005 J. Biol. Chem. pmid:15927959
Schroeder TM and Westendorf JJ Histone deacetylase inhibitors promote osteoblast maturation. 2005 J. Bone Miner. Res. pmid:16294278
Bártová E et al. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. 2005 J. Cell. Sci. pmid:16254244
Fishel ML et al. Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity. 2005 J. Pharmacol. Exp. Ther. pmid:15304523
Xiong Y et al. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. 2005 Cancer Res. pmid:15805266
Kumakura S et al. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. 2005 Cancer Res. pmid:15805278
Zhao W et al. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. 2005 J. Biochem. pmid:15809347
Subramanian C et al. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15778293
Lu ZP et al. Histone deacetylase inhibitor Trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription. 2005 Biochem. Biophys. Res. Commun. pmid:15781251
Nishigaki M et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. 2005 Cancer Res. pmid:15781621
Bai J et al. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. 2005 Cancer Res. pmid:15781649
Rahmani M et al. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. 2005 Cancer Res. pmid:15781658
Frescas D et al. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. 2005 J. Biol. Chem. pmid:15788402
Ezzat S et al. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility. 2005 Mol. Endocrinol. pmid:15618287